Study of MDX-010 in Stage IV Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Adenocarcinoma
Interventions: DRUG: MDX-010
Sponsor: Bristol-Myers Squibb